Patient Monitoring in Chronic Myeloid Leukemia (CML)

The panelists, Jorge Cortes, MD; David Snyder, MD, FACP; Kevin Kelly, MD, PhD; and Harry Erba, MD, PhD, emphasize the importance of medication adherence and monitoring patients during treatment for chronic myeloid leukemia (CML).

• Catégorie